Alternative data datasets
Browse by provider, category, marketplace, access, delivery and license
View source information and access options.
Curated datasets produced by UBS Evidence Lab through its in-house research across numerous alternative-data subject areas.
Public-safe distribution bundle from a local r19 counterexample resolution review of arXiv patents using a language model, containing review-related outputs, manifests, checksums, and provenance receipts, but excluding the original arXiv PDFs and any expert validation.
An independent, rule-based on-chain measurement of tokenized real-world-asset supplies spanning the XRP Ledger and Ethereum, where each record is a verified public-ledger fact rather than a certification, risk score, or signed attestation, distributed via the gspc endpoint across 22 measurement axes (15 populated, 7 left empty).
An analysis-ready compilation of roughly 3,000 ClinicalTrials.gov studies registered between 2000 and 2025 that involve AI, machine learning, or digital-health tools, enriched with 30 LLM-derived variables covering use case, therapeutic area, sponsor composition, trial phase, deployment score, evidence strength, and responsible-AI keyword indicators.
A platform pooling electronic health record information from U.S. healthcare providers to support real-world evidence studies.
A snapshot of processed ClinicalTrials.gov records filtered to completed-recruitment Phase 3 and Phase 4 studies, plus trials of medical devices or behavioral interventions, totaling 156,887 trials as of March 2025, used for an agentic medical retrieval and evidence-grounding system.
Gold Volatility Dynamics: Evidence from U.S.–China Relations.